Brincidofovir
Brincidofovir (brand name: Tembexa) is an oral antiviral medication approved for the treatment of human smallpox disease caused by the variola virus. It is a lipid-conjugated prodrug of cidofovir, designed to improve drug delivery and reduce toxicity. Reference standards of Brincidofovir API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Brincidofovir
[catalogue_number] => PA 02 2790000
[category_ids] => ,70,71,78,80,82,88,
[chemical_name] =>
[weight] => 561.7
[form] => C27H52N3O7P
[cas] => 444805-28-1
[pslug] => 444805-28-1-brincidofovir-pa022790000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
